News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
735,696 Results
Type
Article (41878)
Company Profile (188)
Press Release (693620)
Multimedia
Podcasts (101)
Webinars (21)
Section
Business (234551)
Career Advice (2049)
Deals (35668)
Drug Delivery (134)
Drug Development (81753)
Employer Resources (174)
FDA (16600)
Job Trends (15029)
News (347403)
Policy (32817)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2612)
Accelerated approval (56)
ADA (44)
Adcomms (30)
Allergies (194)
Alliances (49624)
ALS (227)
Alzheimer's disease (1886)
Antibody-drug conjugate (ADC) (535)
Approvals (17090)
Artificial intelligence (745)
ASCO (327)
Autoimmune disease (353)
Automation (64)
Bankruptcy (364)
Best Places to Work (11641)
BIO (71)
BIOSECURE Act (20)
Biosimilars (240)
Biotechnology (123)
Bladder cancer (207)
Brain cancer (75)
Breast cancer (809)
Cancer (6397)
Cardiovascular disease (512)
Career advice (1743)
Career pathing (45)
CAR-T (358)
CDC (58)
Celiac Disease (3)
Cell therapy (977)
Cervical cancer (56)
Clinical research (71758)
Collaboration (2242)
Commercialization (1)
Company closure (5)
Compensation (1541)
Complete response letters (91)
COVID-19 (2759)
CRISPR (118)
C-suite (1278)
Cystic fibrosis (158)
Data (8774)
Decentralized trials (3)
Denatured (29)
Depression (178)
Dermatology (102)
Diabetes (676)
Diagnostics (7062)
Digital health (65)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (369)
Drug pricing (203)
Drug shortages (31)
Duchenne muscular dystrophy (311)
Earnings (92277)
Editorial (68)
Employer branding (22)
Employer resources (156)
Events (120757)
Executive appointments (1144)
FDA (20699)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (36)
Funding (1874)
Gene editing (251)
Generative AI (63)
Gene therapy (759)
GLP-1 (1100)
Government (4764)
Grass and pollen (6)
Guidances (422)
Healthcare (19157)
Hematology (192)
HIV (90)
Huntington's disease (64)
IgA nephropathy (115)
Immunology and inflammation (309)
Immuno-oncology (106)
Indications (224)
Infectious disease (3129)
Inflammatory bowel disease (223)
Inflation Reduction Act (14)
Influenza (144)
Intellectual property (322)
Interviews (326)
IPO (16692)
IRA (50)
Job creations (3666)
Job search strategy (1440)
JPM (59)
Kidney cancer (22)
Labor market (113)
Layoffs (584)
Leadership (42)
Legal (7976)
Liver cancer (105)
Longevity (35)
Lung cancer (848)
Lymphoma (484)
Machine learning (65)
Management (61)
Manufacturing (1178)
Marketing (7)
MASH (211)
Medical affairs (1)
Medical device (14013)
Medtech (14194)
Mergers & acquisitions (20310)
Metabolic disorders (1670)
mRNA (237)
Multiple sclerosis (203)
NASH (17)
Neurodegenerative disease (477)
Neuropsychiatric disorders (111)
Neuroscience (3548)
Neurotech (1)
NextGen: Class of 2026 (6532)
Non-profit (4544)
Now hiring (83)
Obesity (765)
Opinion (305)
Ovarian cancer (243)
Pain (270)
Pancreatic cancer (356)
Parkinson's disease (397)
Partnered (36)
Patents (653)
Patient recruitment (792)
Peanut (68)
People (60051)
Pharmaceutical (45)
Pharmacy benefit managers (33)
Phase 1 (22359)
Phase 2 (31608)
Phase 3 (23543)
Pipeline (10121)
Policy (334)
Postmarket research (2575)
Preclinical (9488)
Press Release (64)
Prostate cancer (339)
Psychedelics (60)
Radiopharmaceuticals (349)
Rare diseases (1207)
Real estate (5982)
Recruiting (72)
Regulatory (25979)
Reports (56)
Research institute (2433)
Resumes & cover letters (355)
Rett syndrome (46)
RNA editing (25)
RSV (90)
Schizophrenia (184)
Series A (318)
Series B (235)
Service/supplier (7)
Sickle cell disease (122)
Special edition (25)
Spinal muscular atrophy (171)
Sponsored (48)
Startups (3658)
State (2)
Stomach cancer (18)
Supply chain (134)
Tariffs (87)
The Weekly (70)
Vaccines (1159)
Venture capital (122)
Weight loss (487)
Women's health (138)
Worklife (21)
Date
Today (97)
Last 7 days (390)
Last 30 days (1984)
Last 365 days (30499)
2026 (16984)
2025 (30187)
2024 (35152)
2023 (40087)
2022 (51198)
2021 (55728)
2020 (54096)
2019 (46574)
2018 (35049)
2017 (32148)
2016 (31508)
2015 (37567)
2014 (31334)
2013 (26378)
2012 (28602)
2011 (29309)
2010 (27345)
Location
Africa (748)
Alabama (95)
Alaska (7)
Arizona (367)
Arkansas (14)
Asia (40039)
Australia (6574)
California (14140)
Canada (4015)
China (1522)
Colorado (603)
Connecticut (617)
Delaware (437)
Europe (86700)
Florida (2145)
Georgia (451)
Hawaii (3)
Idaho (63)
Illinois (1164)
India (101)
Indiana (640)
Iowa (24)
Japan (607)
Kansas (134)
Kentucky (52)
Louisiana (58)
Maine (78)
Maryland (1673)
Massachusetts (10131)
Michigan (377)
Minnesota (761)
Mississippi (6)
Missouri (152)
Montana (33)
Nebraska (30)
Nevada (151)
New Hampshire (84)
New Jersey (3701)
New Mexico (30)
New York (3722)
North Carolina (1773)
North Dakota (9)
Northern California (7154)
Ohio (420)
Oklahoma (24)
Oregon (40)
Pennsylvania (2808)
Puerto Rico (31)
Rhode Island (52)
South America (1117)
South Carolina (89)
South Dakota (2)
Southern California (5623)
Tennessee (232)
Texas (2275)
United States (49864)
Utah (421)
Vermont (2)
Virginia (344)
Washington D.C. (81)
Washington State (1127)
West Virginia (4)
Wisconsin (133)
Wyoming (2)
735,696 Results for "genentech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Genentech culls 103 jobs, inks $490M-plus biobucks deal with Astex
With the latest round, Roche’s Genentech will have racked up nearly 450 layoffs in California over the last year amid ongoing restructuring. At the same time, the biotech is joining forces with Astex Pharmaceuticals in a deal that could surpass $490 million.
July 6, 2026
·
2 min read
·
Gabrielle Masson
Layoffs
Genentech R&D layoffs hit top exec who’s been with the biotech nearly 30 years
The staffing changes will focus resources on work that creates the highest impact for patients, according to Genentech. The number of employees affected is unknown, but longtime veteran Vishva Dixit is out.
June 11, 2026
·
1 min read
·
Angela Gabriel
Press Releases
FDA Grants Priority Review for Genentech’s Tecentriq for a Certain Type of Stage III Colon Cancer
June 11, 2026
·
14 min read
Press Releases
FDA Grants Priority Review To Genentech’s Application for Enspryng, the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)
June 30, 2026
·
10 min read
Press Releases
Genentech’s Divarasib Shows Superiority in Head-to-Head Phase III Trial Against Approved KRAS G12C Inhibitors in Non-Small Cell Lung Cancer
July 2, 2026
·
5 min read
Press Releases
FDA Approves Genentech’s Tecentriq for Adjuvant Muscle-Invasive Bladder Cancer With ctDNA-Guided Treatment
May 17, 2026
·
10 min read
Layoffs
Genentech’s Latest Layoffs Bring Total to Nearly 350 This Year
Genentech is letting go of 118 employees in South San Francisco. The news comes about two months after the biotech ended a partnership with Adaptive Biotechnologies.
October 29, 2025
·
1 min read
·
Angela Gabriel
Press Releases
FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus
April 21, 2026
·
14 min read
Press Releases
Astex Announces Exclusive Research Collaboration and License Agreement with Genentech for Breast Cancer Therapy Program
July 6, 2026
·
3 min read
Press Releases
CORRECTING and REPLACING FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus
April 21, 2026
·
15 min read
1 of 73,570
Next
